桥接溶栓在心血管闭塞后优于直接取栓:更新荟萃分析
该荟萃分析比较桥接溶栓(BT,静脉溶栓+机械取栓)与直接机械取栓(d-MT)在大血管闭塞性缺血性卒中后的结局。结果显示BT组90天功能独立率更高、死亡率更低、成功再通率更高,且症状性颅内出血无显著差异。
要点
- 桥接溶栓较直接取栓显著提高90天功能独立率(OR=1.43)。
- 桥接溶栓组90天死亡率显著更低(OR=0.67)。
- 两组症状性颅内出血风险无显著差异(OR=1.01)。
核心结论
- 与直接取栓相比,桥接溶栓带来更好的临床结局、更低的90天死亡率和更高的成功再通率,且不增加近期出血并发症风险。
研究设计与样本
- 检索MEDLINE、EMBASE、Scopus和Cochrane Library(2017年1月至2020年6月)中直接比较两种策略结局的研究。
- 使用Quality in Prognostic Studies工具评估方法学质量,合并估计桥接溶栓对比直接取栓的比值比(OR)。
主要发现
- 桥接溶栓组90天功能独立(改良Rankin量表评分0-2)显著优于直接取栓组(OR=1.43 [95% CI, 1.28-1.61])。
- 桥接溶栓组90天死亡率显著低于直接取栓组(OR=0.67 [95% CI, 0.60-0.75])。
- 桥接溶栓组成功再通(改良脑缺血溶栓评分2b-3)率显著高于直接取栓组(OR=1.23 [95% CI, 1.07-1.42])。
- 两组症状性颅内出血发生率无显著差异(OR=1.01 [95% CI, 0.86-1.19])。
- 亚组分析显示,无论静脉溶栓资格或研究设计如何,桥接溶栓组功能独立频率均显著更高。
关键数值与推荐
- 功能独立定义为90天改良Rankin量表评分0-2。
- 成功再通定义为改良脑缺血溶栓评分2b-3。
临床怎么用
- 对于大血管闭塞性缺血性卒中患者,桥接溶栓(静脉溶栓后机械取栓)可带来更好功能结局且不增加出血风险,支持当前指南使用桥接溶栓。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The utility and necessity of pretreatment with intravenous thrombolysis (IVT) before mechanical thrombectomy (MT) remains an issue of strong debate. This study aims to compare the outcomes of bridging thrombolysis (BT, IVT+MT) with direct MT (d-MT) after large vessel ischemic stroke based on the most up-to-date evidence. MEDLINE, EMBASE, Scopus, and the Cochrane Library from January 2017 to June 2020 were searched for studies that directly compared the outcomes of the 2 strategies. Methodological quality was assessed using the Quality in Prognostic Studies tool. Combined estimates of odds ratios (ORs) of BT versus d-MT were derived. Multiple subgroup analyses were performed, especially for IVT-eligible patients. Thirty studies involving 7191 patients in the BT group and 4891 patients in the d-MT group were included. Methodological quality was generally high. Compared with patients in the d-MT group, patients in the BT group showed significantly better functional independence (modified Rankin Scale score 0-2) at 90 days (OR=1.43 [95% CI, 1.28-1.61]), had lower mortality at 90 days (OR=0.67 [95% CI, 0.60-0.75]), and achieved higher successful recanalization (modified Thrombolysis in Cerebral Ischemia score 2b-3) rate (OR=1.23 [95% CI, 1.07-1.42]). No significant difference was detected in the occurrence of symptomatic intracranial hemorrhage between 2 groups (OR=1.01 [95% CI, 0.86-1.19]). Subgroup analysis showed that functional independence frequency remained significantly higher in BT group regardless of IVT eligibility or study design. Compared with d-MT, bridging with IVT led to better clinical outcomes, lower mortality at 90 days, and higher successful recanalization rates, without increasing the risk of near-term hemorrhagic complications. The benefits of BT based on this most recent literature evidence support the current guidelines of using BT.
引用
- Wang Y, Wu X, Zhu C, et al. Bridging Thrombolysis Achieved Better Outcomes Than Direct Thrombectomy After Large Vessel Occlusion: An Updated Meta-Analysis. Stroke. 2020. PMID: 33302795. doi:10.1161/STROKEAHA.120.031477
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。